CD80 and oral cavity squamous cell carcinoma: Moreover, Das et al. reported that the potential immunosuppressive effect in gingivobuccal oral squamous cell carcinoma (OSCC-GB) may be associated with promoter hypomethylation, which was driven by the upregulation of CD80 [54].